Angermann CE, Sehner S, Gerhardt LMS, Santos-Gallego CG, et al. Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial. Eur Heart J 2025 Feb 5:ehae917. doi: 10.1093.
PMID: 39907687